SMPDB ID,Pathway Name,Pathway Subject,Metabolite ID,Metabolite Name,HMDB ID,KEGG ID,ChEBI ID,DrugBank ID,CAS,Formula,IUPAC,SMILES,InChI,InChI Key
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000723,Citrulline,HMDB0000904,C00327,16349,DB00155,372-75-8,C6H13N3O3,(2S)-2-amino-5-(carbamoylamino)pentanoic acid,N[C@@H](CCCNC(N)=O)C(O)=O,"InChI=1S/C6H13N3O3/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1",RHGKLRLOHDJJDR-BYPYZUCNSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000862,Carbamoyl phosphate,HMDB0001096,C00169,17672,"",590-55-6,CH4NO5P,(carbamoyloxy)phosphonic acid,NC(=O)OP(O)(O)=O,"InChI=1S/CH4NO5P/c2-1(3)7-8(4,5)6/h(H2,2,3)(H2,4,5,6)",FFQKYPRQEYGKAF-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000140,Ornithine,HMDB0000214,C00077,15729,DB00129,70-26-8,C5H12N2O2,"(2S)-2,5-diaminopentanoic acid",NCCC[C@H](N)C(O)=O,"InChI=1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/t4-/m0/s1",AHLPHDHHMVZTML-BYPYZUCNSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000414,Adenosine triphosphate,HMDB0000538,C00002,15422,DB00171,56-65-5,C10H16N5O13P3,"({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,"InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",ZKHQWZAMYRWXGA-KQYNXXCUSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000123,L-Aspartic acid,HMDB0000191,C00049,17053,DB00128,56-84-8,C4H7NO4,(2S)-2-aminobutanedioic acid,N[C@@H](CC(O)=O)C(O)=O,"InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1",CKLJMWTZIZZHCS-REOHCLBHSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000032,Adenosine monophosphate,HMDB0000045,C00020,16027,DB00131,61-19-8,C10H14N5O7P,"{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid",NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",UDMBCSSLTHHNCD-KQYNXXCUSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000170,Pyrophosphate,HMDB0000250,C00013,18361,DB04160,14000-31-8,O7P2,(phosphonooxy)phosphonate,[O-]P([O-])(=O)OP([O-])([O-])=O,"InChI=1S/H4O7P2/c1-8(2,3)7-9(4,5)6/h(H2,1,2,3)(H2,4,5,6)/p-4",XPPKVPWEQAFLFU-UHFFFAOYSA-J
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000036,Argininosuccinic acid,HMDB0000052,C03406,15682,,2387-71-5,C10H18N4O6,(2S)-2-{3-[(4S)-4-amino-4-carboxybutyl]carbamimidamido}butanedioic acid,N[C@@H](CCCNC(=N)N[C@@H](CC(O)=O)C(O)=O)C(O)=O,"InChI=1S/C10H18N4O6/c11-5(8(17)18)2-1-3-13-10(12)14-6(9(19)20)4-7(15)16/h5-6H,1-4,11H2,(H,15,16)(H,17,18)(H,19,20)(H3,12,13,14)/t5-,6-/m0/s1",KDZOASGQNOPSCU-WDSKDSINSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000088,Fumaric acid,HMDB0000134,C00122,18012,DB04299,110-17-8,C4H4O4,(2E)-but-2-enedioic acid,OC(=O)\C=C\C(O)=O,"InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1+",VZCYOOQTPOCHFL-OWOJBTEDSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000396,L-Arginine,HMDB0000517,C00062,16467,DB00125,74-79-3,C6H14N4O2,(2S)-2-amino-5-carbamimidamidopentanoic acid,N[C@@H](CCCNC(N)=N)C(O)=O,"InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1",ODKSFYDXXFIFQN-BYPYZUCNSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000035,Ammonia,HMDB0000051,C00014,16134,,7664-41-7,H3N,ammonia,N,InChI=1S/H3N/h1H3,QGZKDVFQNNGYKY-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001316,Carbon dioxide,HMDB0001967,C00011,16526,"",124-38-9,CO2,methanedione,O=C=O,InChI=1S/CO2/c2-1-3,CURLTUGMZLYLDI-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001420,Water,HMDB0002111,C00001,15377,,7732-18-5,H2O,water,O,InChI=1S/H2O/h1H2,XLYOFNOQVPJJNP-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001034,Adenosine diphosphate,HMDB0001341,C00008,16761,,58-64-0,C10H15N5O10P2,"[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",XTWYTFMLZFPYCI-KQYNXXCUSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001441,Phosphoric acid,HMDB0002142,C00009,26078,,7664-38-2,H3O4P,phosphoric acid,OP(O)(O)=O,"InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)",NBIIXXVUZAFLBC-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000095,L-Glutamic acid,HMDB0000148,C00025,16015,DB00142,56-86-0,C5H9NO4,(2S)-2-aminopentanedioic acid,N[C@@H](CCC(O)=O)C(O)=O,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",WHUUTDBJXJRKMK-VKHMYHEASA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000721,NAD,HMDB0000902,C00003,15846,,53-84-9,C21H28N7O14P2,"1-[(2R,3R,4S,5R)-5-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium",NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,"InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/p+1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",BAWFJGJZGIEFAR-NNYOXOHSSA-O
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000134,Oxoglutaric acid,HMDB0000208,C00026,30915,DB02926,328-50-7,C5H6O5,2-oxopentanedioic acid,OC(=O)CCC(=O)C(O)=O,"InChI=1S/C5H6O5/c6-3(5(9)10)1-2-4(7)8/h1-2H2,(H,7,8)(H,9,10)",KPGXRSRHYNQIFN-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001144,NADH,HMDB0001487,C00004,16908,DB00157,58-68-4,C21H29N7O14P2,"[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinic acid",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O,"InChI=1S/C21H29N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1,3-4,7-8,10-11,13-16,20-21,29-32H,2,5-6H2,(H2,23,33)(H,34,35)(H,36,37)(H2,22,24,25)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",BOPGDPNILDQYTO-NNYOXOHSSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001415,L-Glutamic gamma-semialdehyde,HMDB0002104,C01165,17232,DB04388,496-92-4,C5H9NO3,(2S)-2-amino-5-oxopentanoic acid,N[C@@H](CCC=O)C(O)=O,"InChI=1S/C5H9NO3/c6-4(5(8)9)2-1-3-7/h3-4H,1-2,6H2,(H,8,9)/t4-/m0/s1",KABXUUFDPUOJMW-BYPYZUCNSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001148,Pyridoxal 5'-phosphate,HMDB0001491,C00018,18405,DB00114,54-47-7,C8H10NO6P,[(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methoxy]phosphonic acid,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O,"InChI=1S/C8H10NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2-3,11H,4H2,1H3,(H2,12,13,14)",NGVDGCNFYWLIFO-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C040034,Hydrogen Ion,HMDB0059597,C00080,15378,,,H,hydron,[H+],InChI=1S/p+1,GPRLSGONYQIRFK-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001003,1-Pyrroline-5-carboxylic acid,HMDB0001301,C04322,1372,"",2906-39-0,C5H7NO2,"3,4-dihydro-2H-pyrrole-2-carboxylic acid",OC(=O)C1CCC=N1,"InChI=1S/C5H7NO2/c7-5(8)4-2-1-3-6-4/h3-4H,1-2H2,(H,7,8)",DWAKNKKXGALPNW-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000106,L-Proline,HMDB0000162,C00148,17203,DB00172,147-85-3,C5H9NO2,(2S)-pyrrolidine-2-carboxylic acid,OC(=O)[C@@H]1CCCN1,"InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1",ONIBWKKTOPOVIA-BYPYZUCNSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000964,FAD,HMDB0001248,C00016,16238,DB03147,146-14-5,C27H33N9O15P2,"[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-2H,3H,4H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl]oxy})phosphinic acid",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2,"InChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1",VWWQXMAJTJZDQX-UYBVJOGSSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001065,Oxygen,HMDB0001377,C00007,15379,,7782-44-7,O2,oxidanone,O=O,InChI=1S/O2/c1-2,MYMOFIZGZYHOMD-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C002643,4-Hydroxyproline,HMDB0000725,C01157,18095,,51-35-4,C5H9NO3,"(2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid",O[C@H]1CN[C@@H](C1)C(O)=O,"InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1",PMMYEEVYMWASQN-DMTCNVIQSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000174,Succinic acid,HMDB0000254,C00042,15741,DB00139,110-15-6,C4H6O4,butanedioic acid,OC(=O)CCC(O)=O,"InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)",KDYFGRWQOYBRFD-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001057,Pyrroline hydroxycarboxylic acid,HMDB0001369,C04281,27391,,22573-88-2,C5H7NO3,"4-hydroxy-3,4-dihydro-2H-pyrrole-2-carboxylic acid",OC1CC(N=C1)C(O)=O,"InChI=1S/C5H7NO3/c7-3-1-4(5(8)9)6-2-3/h2-4,7H,1H2,(H,8,9)",WFOFKRKDDKGRIK-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000078,Glycine,HMDB0000123,C00037,15428,DB00145,56-40-6,C2H5NO2,2-aminoacetic acid,NCC(O)=O,"InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)",DHMQDGOQFOQNFH-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000083,Guanidoacetic acid,HMDB0000128,C00581,16344,DB02751,352-97-6,C3H7N3O2,2-carbamimidamidoacetic acid,NC(=N)NCC(O)=O,"InChI=1S/C3H7N3O2/c4-3(5)6-1-2(7)8/h1H2,(H,7,8)(H4,4,5,6)",BPMFZUMJYQTVII-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000921,S-Adenosylmethionine,HMDB0001185,C00019,15414,DB00118,485-80-3,C15H23N6O5S,"[(3S)-3-amino-3-carboxypropyl]({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl})methylsulfanium",C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7-,8+,10+,11+,14+,27?/m0/s1",MEFKEPWMEQBLKI-AIRLBKTGSA-O
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000749,S-Adenosylhomocysteine,HMDB0000939,C00021,16680,"",979-92-0,C14H20N6O5S,"(2S)-2-amino-4-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfanyl)butanoic acid",N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N)C(O)=O,"InChI=1S/C14H20N6O5S/c15-6(14(23)24)1-2-26-3-7-9(21)10(22)13(25-7)20-5-19-8-11(16)17-4-18-12(8)20/h4-7,9-10,13,21-22H,1-3,15H2,(H,23,24)(H2,16,17,18)/t6-,7+,9+,10+,13+/m0/s1",ZJUKTBDSGOFHSH-WFMPWKQPSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000046,Creatine,HMDB0000064,C00300,16919,DB00148,57-00-1,C4H9N3O2,2-(N-methylcarbamimidamido)acetic acid,CN(CC(O)=O)C(N)=N,"InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)",CVSVTCORWBXHQV-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001164,Phosphocreatine,HMDB0001511,C02305,17287,,67-07-2,C4H10N3O5P,2-(3-methyl-1-phosphonocarbamimidamido)acetic acid,CN(CC(O)=O)C(=N)NP(O)(O)=O,"InChI=1S/C4H10N3O5P/c1-7(2-3(8)9)4(5)6-13(10,11)12/h2H2,1H3,(H,8,9)(H4,5,6,10,11,12)",DRBBFCLWYRJSJZ-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000200,Urea,HMDB0000294,C00086,16199,DB03904,57-13-6,CH4N2O,urea,NC(N)=O,"InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)",XSQUKJJJFZCRTK-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001027,Manganese,HMDB0001333,C19610,29035,,16397-91-4,Mn,manganese(2+) ion,[Mn++],InChI=1S/Mn/q+2,WAEMQWOKJMHJLA-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001104,Phosphate,HMDB0001429,C00009,18367,"",14265-44-2,O4P,phosphate,[O-]P([O-])([O-])=O,"InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-3",NBIIXXVUZAFLBC-UHFFFAOYSA-K
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001878,D-Proline,HMDB0003411,C00763,16313,,344-25-2,C5H9NO2,(2R)-pyrrolidine-2-carboxylic acid,OC(=O)[C@H]1CCCN1,"InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m1/s1",ONIBWKKTOPOVIA-SCSAIBSYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C002984,1-Pyrroline-2-carboxylic acid,HMDB0006875,C03564,36761,DB02838,2139-03-9,C5H7NO2,"3,4-dihydro-2H-pyrrol-1-ium-5-carboxylate",[O-]C(=O)C1=[NH+]CCC1,"InChI=1S/C5H7NO2/c7-5(8)4-2-1-3-6-4/h1-3H2,(H,7,8)",RHTAIKJZSXNELN-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001783,Hydrogen peroxide,HMDB0003125,C00027,16240,,7722-84-1,H2O2,peroxol,OO,InChI=1S/H2O2/c1-2/h1-2H,MHAJPDPJQMAIIY-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001512,1-Pyrroline-4-hydroxy-2-carboxylate,HMDB0002234,C04282,16352,,9054-77-7,C5H7NO3,"3-hydroxy-3,4-dihydro-2H-pyrrole-5-carboxylic acid",OC1CN=C(C1)C(O)=O,"InChI=1S/C5H7NO3/c7-3-1-4(5(8)9)6-2-3/h3,7H,1-2H2,(H,8,9)",AOMLMYXPXUTBQH-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001535,4-Hydroxy-L-glutamic acid,HMDB0002273,C03079,16338,,2485-33-8,C5H7NO5,(2S)-2-amino-4-hydroxypentanedioate,N[C@@H](CC(O)C([O-])=O)C([O-])=O,"InChI=1S/C5H9NO5/c6-2(4(8)9)1-3(7)5(10)11/h2-3,7H,1,6H2,(H,8,9)(H,10,11)/p-2/t2-,3?/m0/s1",HBDWQSHEVMSFGY-SCQFTWEKSA-L
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000146,NADPH,HMDB0000221,C00005,16474,"",53-57-6,C21H30N7O17P3,"{[(2S,3S,4S,5S)-2-(6-amino-9H-purin-9-yl)-5-[({[({[(2S,3R,4S,5S)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-4-hydroxyoxolan-3-yl]oxy}phosphonic acid",NC(=O)C1=CN(C=CC1)[C@H]1O[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2O[C@@H]([C@@H](OP(O)(O)=O)[C@H]2O)N2C=NC3=C(N)N=CN=C23)[C@H](O)[C@@H]1O,"InChI=1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/t10-,11-,13-,14-,15-,16-,20-,21-/m0/s1",ACFIXJIJDZMPPO-NCHANQSKSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C002808,L-4-Hydroxyglutamate semialdehyde,HMDB0006556,C05938,27809,,,C5H9NO4,"(2S,4R)-2-amino-4-hydroxy-5-oxopentanoic acid",N[C@@H](C[C@@H](O)C=O)C(O)=O,"InChI=1S/C5H9NO4/c6-4(5(9)10)1-3(8)2-7/h2-4,8H,1,6H2,(H,9,10)/t3-,4+/m1/s1",XCXUZPXOFFRGGP-DMTCNVIQSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000148,Oxalacetic acid,HMDB0000223,C00036,30744,,328-42-7,C4H4O5,2-oxobutanedioic acid,OC(=O)CC(=O)C(O)=O,"InChI=1S/C4H4O5/c5-2(4(8)9)1-3(6)7/h1H2,(H,6,7)(H,8,9)",KHPXUQMNIQBQEV-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001391,4-Hydroxy-2-oxoglutaric acid,HMDB0002070,C01127,30923,,1187-99-1,C5H6O6,2-hydroxy-4-oxopentanedioic acid,OC(CC(=O)C(O)=O)C(O)=O,"InChI=1S/C5H6O6/c6-2(4(8)9)1-3(7)5(10)11/h2,6H,1H2,(H,8,9)(H,10,11)",WXSKVKPSMAHCSG-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C002093,N(omega)-Hydroxyarginine,HMDB0004224,C05933,43088,DB03144,53054-07-2,C6H14N4O3,(2S)-2-amino-5-[(Z)-N''-hydroxycarbamimidamido]pentanoic acid,N[C@@H](CCCNC(=N)NO)C(O)=O,"InChI=1S/C6H14N4O3/c7-4(5(11)12)2-1-3-9-6(8)10-13/h4,13H,1-3,7H2,(H,11,12)(H3,8,9,10)/t4-/m0/s1",FQWRAVYMZULPNK-BYPYZUCNSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001867,Nitric oxide,HMDB0003378,C00533,16480,DB00435,10102-43-9,NO,nitroso,[N]=O,InChI=1S/NO/c1-2,MWUXSHHQAYIFBG-UHFFFAOYSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000143,NADP,HMDB0000217,C00006,18009,,53-59-8,C21H29N7O17P3,"1-[(2R,3R,4S,5R)-5-[({[({[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium",NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O,"InChI=1S/C21H28N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1-4,7-8,10-11,13-16,20-21,29-31H,5-6H2,(H7-,22,23,24,25,32,33,34,35,36,37,38,39)/p+1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",XJLXINKUBYWONI-NNYOXOHSSA-O
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001799,Heme,HMDB0003178,C00032,17627,DB02577,14875-96-8,C34H32FeN4O4,"(1R)-15,19-bis(2-carboxyethyl)-5,10-diethenyl-4,9,14,20-tetramethyl-2λ⁵,22,23λ⁵,25-tetraaza-1-ferraoctacyclo[11.9.1.1¹,⁸.1³,²¹.0²,⁶.0¹⁶,²³.0¹⁸,²².0¹¹,²⁵]pentacosa-2,4,6,8,10,12,14,16(23),17,19,21(24)-undecaene-2,23-bis(ylium)",CC1=C(CCC(O)=O)C2=CC3=[N+]4C(=CC5=C(C=C)C(C)=C6C=C7C(C=C)=C(C)C8=[N+]7[Fe@]4(N2C1=C8)N56)C(C)=C3CCC(O)=O,"InChI=1S/C34H34N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);/q;+4/p-2/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-;",YHLKGEDAGPGZPN-RGGAHWMASA-L
SMP0000361,Hyperprolinemia Type I,Disease,PW_C001170,Flavin Mononucleotide,HMDB0001520,C00061,17621,DB03247,146-17-8,C17H21N4O9P,"{[(2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-2H,3H,4H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl]oxy}phosphonic acid",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2,"InChI=1S/C17H21N4O9P/c1-7-3-9-10(4-8(7)2)21(15-13(18-9)16(25)20-17(26)19-15)5-11(22)14(24)12(23)6-30-31(27,28)29/h3-4,11-12,14,22-24H,5-6H2,1-2H3,(H,20,25,26)(H2,27,28,29)/t11-,12+,14-/m0/s1",FVTCRASFADXXNN-SCRDCRAPSA-N
SMP0000361,Hyperprolinemia Type I,Disease,PW_C000019,Tetrahydrobiopterin,HMDB0000027,C00272,15372,DB00360,17528-72-2,C9H15N5O3,"2-amino-6-(1,2-dihydroxypropyl)-1,4,5,6,7,8-hexahydropteridin-4-one",CC(O)C(O)C1CNC2=C(N1)C(=O)N=C(N)N2,"InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)",FNKQXYHWGSIFBK-UHFFFAOYSA-N
